We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

186 hedge funds and large institutions have $2.59B invested in Sarepta Therapeutics in 2016 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 54 increasing their positions, 52 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

292% more capital invested

Capital invested by funds: $661M → $2.59B (+$1.93B)

267% more funds holding in top 10

Funds holding in top 10: 3 → 11 (+8)

158% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 24

26% more funds holding

Funds holding: 148 → 186 (+38)

4% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 52

33% less call options, than puts

Call options by funds: $524M | Put options by funds: $780M

Holders
186
Holders Change
+38
Holders Change %
+25.68%
% of All Funds
4.96%
Holding in Top 10
11
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+266.67%
% of All Funds
0.29%
New
62
Increased
54
Reduced
52
Closed
24
Calls
$524M
Puts
$780M
Net Calls
-$256M
Net Calls Change
-$90.9M

Top Buyers

Rank Fund Capital Flow
1
TCP
Tourbillon Capital Partners
New York
+$51.8M
2
JG
Jefferies Group
New York
+$49.3M
3
Millennium Management
Millennium Management
New York
+$48.7M
4
BA
BlackRock Advisors
Delaware
+$21.1M
5
RG
Redmile Group
California
+$19.4M

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$17.3M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$15.7M
3
Morgan Stanley
Morgan Stanley
New York
-$14.6M
4
CWAM
Columbia Wanger Asset Management
Illinois
-$12.2M
5
PA
Perceptive Advisors
New York
-$11.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
176
TIAA CREF Investment Management
New York
$15.4K -$255K -8,422 -3%
GWM
177
Geneos Wealth Management
Colorado
$15K -$1.51K -50 -17%
US Bancorp
178
US Bancorp
Minnesota
$7K – – –
CHP
179
Cable Hill Partners
Oregon
$7K +$3.36K +111 New
WP
180
WealthPLAN Partners
Nebraska
$6.15K +$3.02K +100 New
PCA
181
Peddock Capital Advisors
Massachusetts
$3K +$1.63K +54 New
RAM
182
Riggs Asset Management
Pennsylvania
$2K -$1.21K -40 -53%
MWM
183
MinichMacGregor Wealth Management
New York
$2K – – –
VOYA Investment Management
184
VOYA Investment Management
Georgia
$1.12K – – –
IWMPD
185
Integrated Wealth Management (Palm Desert)
California
$1K – – –
QI
186
QS Investors
New York
$1K +$242 +8 New
CWAM
187
Columbia Wanger Asset Management
Illinois
– -$12.2M -641,932 Closed
Group One Trading
188
Group One Trading
Illinois
– -$17.3M -571,145 Closed
MP
189
Mangrove Partners
Connecticut
– -$9.39M -492,500 Closed
MSU
190
Mizuho Securities USA
New York
– -$3.33M -174,400 Closed
QIM
191
Quantitative Investment Management
Virginia
– -$3.2M -167,800 Closed
Simplex Trading
192
Simplex Trading
Illinois
– -$1.04M -34,308 Closed
FMBTD
193
First Midwest Bank Trust Division
Illinois
– -$628K -32,954 Closed
CIBC World Market
194
CIBC World Market
Ontario, Canada
– -$529K -27,745 Closed
SEC
195
Seven Eight Capital
New York
– -$483K -25,302 Closed
AC
196
Amici Capital
New York
– -$477K -25,000 Closed
Jacobs Levy Equity Management
197
Jacobs Levy Equity Management
New Jersey
– -$349K -18,300 Closed
HCA
198
Harbour Capital Advisors
Virginia
– -$335K -17,550 Closed
QOP
199
Quinn Opportunity Partners
Virginia
– -$334K -17,500 Closed
Commonwealth Equity Services
200
Commonwealth Equity Services
Massachusetts
– -$302K -15,828 Closed
5 6 7
8
9

SRPT Hedge Fund Activity: Q3 2016 in Review

186 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q3 2016, worth a combined $2.59B — up 292% from $661M a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new SRPT positions and 24 closed out — a net gain of 38 holders — while 54 added to existing stakes and 52 trimmed.

The largest buyer was Tourbillon Capital Partners, opening a new position worth an estimated $51.8M. The largest seller was Group One Trading, exiting entirely with an estimated $17.3M sold.

  • 186 institutional investors held Sarepta Therapeutics (SRPT) as of Q3 2016, up from 148 in Q2 2016.
  • Funds reported $2.59B of Sarepta Therapeutics stock for Q3 2016, up 292% quarter-over-quarter.
  • 62 funds opened new Sarepta Therapeutics positions in Q3 2016 and 24 closed out, a net change of +38 holders.
  • The largest Sarepta Therapeutics buyer in Q3 2016 was Tourbillon Capital Partners, an estimated $51.8M added.
  • The largest Sarepta Therapeutics seller in Q3 2016 was Group One Trading, an estimated $17.3M sold.

Based on aggregated 13F filings for Q3 2016.